Elevated levels of hs-crp are associated with high prevalence of depression in japanese patients with type 2 diabetes: The diabetes distress and care registry at tenri (DDCRT 6)

Diabetes Care

Volumn 37, Issue 9, 2014, Pages 2459-2465

  Hayashino, Yasuaki ^a   Mashitani, Tsuyoshi ^a   Tsujii, Satoru ^a   Ishii, Hitoshi ^a  

^a TENRI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C;

AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXERCISE; FEMALE; GENDER; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; SMOKING; ADULT; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; JAPAN; METABOLISM; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; REGISTER; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES;

EID: 84906678187     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2312     Document Type: Article

References (44)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001;24:1069-1078
2. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008;31: 2398-2403
3. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: A meta-analysis. Psychosom Med 2001;63:619-630
4. van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLoS ONE 2013;8:e57058
5. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA2008; 299:2751-2759
6. Hood KK, Lawrence JM, Anderson A, et al.; SEARCH for Diabetes in Youth Study Group. Metabolic and inflammatory links to depression in youth with diabetes. Diabetes Care 2012;35: 2443-2446
7. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27: 24-31
8. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007;21:153-160
9. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998;14:129-151
10. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocytederived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002;32(Suppl. 3): 24-34
11. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823
12. Dentino AN, Pieper CF, Rao MK, et al. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999;47:6-11
13. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong SY, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci 1999;54:M434-M439
14. Maes M, Van Bockstaele DR, Gastel A, et al. The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology 1999;39: 1-9
15. Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001;58:445-452
16. Doyle TA, de Groot M, Harris T, et al. Diabetes, depressive symptoms, and inflammation in older adults: results from the health, aging, and body composition study. J Psychosom Res 2013;75:419-424
17. Tsujii S, Hayashino Y, Ishii H; Diabetes Distress and Care Registry at Tenri Study Group. Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 1). Diabet Med 2012;29:1451-1455
18. Hayashino Y, Okamura S, Matsunaga S, Tsujii S, Ishii H, Group TTCS; Tenri Cohort Study Group. The association between problem areas in diabetes scale scores and glycemic control is modified by types of diabetes therapy: Diabetes Distress and Care Registry in Tenri (DDCRT 2). Diabetes Res Clin Pract 2012;97:405-410
19. Mashitani T, Hayashino Y, Okamura S, et al. Patient-reported adherence to insulin regimen is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3). Diabetes Res Clin Pract 2013;100:189-194
20. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 2010;1:212-228
21. Craig CL, Marshall AL, Sjöström M, et al. International physical activity questionnaire: 12- country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395
22. Spitzer RL, Williams JB, Gibbon M. Instruction manual for the structured clinical interview for DSM-III-R. In Biometrics Research Development. New York, New York State Psychiatric Institute, 1986, p. 4-13
23. Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992;49:624-629
24. van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res 2010;10:235
25. Williams LS, Brizendine EJ, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke 2005;36:635-638
26. Kroenke K, Spitzer RL,Williams JB. The PHQ- 9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613
27. NHS National Institute for Health and Clinical Excellence (NICE). Type 1 diabetes diagnosis and management of type 1 diabetes in children and young people. Clinical Guideline 15, developed by the National Collaborating Centre for Woman's and Children's Health and the National Collaborating Centre for Chronic Conditions, 2004
28. Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH. Biological basis of depression in adults with diabetes. Curr Diab Rep 2010;10:396-405
29. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334
30. Spranger J, Kroke A,Möhlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective populationbased European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52:812-817
31. Bertoni AG, Burke GL, Owusu JA, et al. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2010;33:804-810
32. Brummett BH, Boyle SH, Ortel TL, Becker RC, Siegler IC, Williams RB. Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom Med 2010;72:333-339
33. Kobrosly R, van Wijngaarden E. Associations between immunologic, inflammatory, and oxidative stress markers with severity of depressive symptoms: An analysis of the 2005-2006 National Health and Nutrition Examination Survey. Neurotoxicology 2010;31: 126-133
34. Elovainio M, Aalto AM, Kivimäki M, et al. Depression and C-reactive protein: populationbased Health 2000 Study. Psychosom Med 2009;71:423-430
35. Stewart JC, Rand KL, Muldoon MF, Kamarck TW. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009;23:936-944
36. Gimeno D, Kivimäki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009;39:413-423
37. Wang X, Bao W, Liu J, et al. Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2013; 36:166-175
38. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
39. Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C. Lifestyle interventions for patients with and at risk for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med 2013;159:543-551
40. Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: A systematic review and meta-analysis. JAMA 2011;305:1790-1799
41. Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S. Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 2012;98:349-360
42. Gellis ZD, Kang-Yi C. Meta-analysis of the effect of cardiac rehabilitation interventions on depression outcomes in adults 64 years of age and older. Am J Cardiol 2012;110:1219-1224
43. Hayashino Y, Jackson JL, Hirata T, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: A meta-analysis of randomized controlled trials. Metabolism 2014;63:431-440
44. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol 1990;132:746-748